Weekly Recap | Bristol Myers Squibb -0.91%, consensus target above spotWeekly Review·Sep 19 at 05:46 AMBMY0.00%
9 Health Care Stocks Whale Activity In Today’s Sessionbenzinga_article·Sep 18 at 05:35 PMMRNS0.00%AMGN0.00%
Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared To CompetitorsMarketWatch Automated·Sep 17 at 08:36 PMBMY0.00%
Bristol Myers Squibb’s Psoriatic Arthritis Pill Shows Durable Efficacy After Two Yearsbenzinga_article·Sep 17 at 03:45 PMBMY0.00%
AstraZeneca, Leidos, Expeditors International And More On CNBC’s ‘Final Trades’benzinga_article·Sep 15 at 11:39 AMEXPD0.00%AZN0.00%
Bispecifics Market to Gain Momentum During the Forecast Period (2026-2036) with Expanding Pipeline and Increasing Therapeutic Adoption | DelveInsightprnewswire·Sep 14 at 02:32 PMRHHBY0.00%BMY0.00%
Weekly Recap | Bristol Myers Squibb -4.76%, positive CAR-T data but studies pausedWeekly Review·Sep 12 at 07:50 AMBMY0.00%
RBC Capital Reaffirms Their Hold Rating on Bristol-Myers Squibb (BMY)Tip Ranks·Sep 11 at 01:45 AMBMY0.00%
Bristol Myers’ EVP, Chief Medical Officer Cristian Massacesi disposes of 6,249 common shares worth $403,700.93PUBT·Sep 10 at 08:38 PMBMY0.00%
BMY Targets Pediatric MS Edge With New Ozanimod Study Against FingolimodTip Ranks·Sep 10 at 04:31 PMBMY0.00%
